{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:54:12Z","timestamp":1791903252820,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1053\/ajkd.2002.32402","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:11:42Z","timestamp":1206047502000},"page":"637-2","source":"Crossref","is-referenced-by-count":9,"title":["Genetics in kidney disease: How much do we want to know?"],"prefix":"10.1053","volume":"39","author":[{"given":"Rita","family":"Kielstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Martin","family":"Sass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2002.32402_bib1","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/nar\/18.10.3106-a","article-title":"A taq1 polymorphism identified by 26-6 (D16S125) proximal to the locus affecting adult polycystic kidney disease (PKD1) on chromosome 16","volume":"18","author":"Breuning","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/ajkd.2002.32402_bib2","article-title":"Some Cultural and Ethical Reflections on Moleculargenetic Risk Assessment","volume":"vol II","author":"Sass","year":"1995"},{"key":"10.1053\/ajkd.2002.32402_bib3","first-page":"173","article-title":"Klinik, Genetik und Ethik der Autosomal Dominant Polyzystischen Nierenerkrankung","author":"Kielstein","year":"1998"},{"key":"10.1053\/ajkd.2002.32402_bib4","series-title":"Goals and Results of Exercise Training in ESRD Patients","author":"Kielstein","year":"1995"},{"key":"10.1053\/ajkd.2002.32402_bib5","first-page":"459","article-title":"The First Ten Years of the W.H.O","author":"World Health Organization","year":"1958"},{"key":"10.1053\/ajkd.2002.32402_bib6","first-page":"24","article-title":"Genetics: Ethical issues in kidney disease","author":"Kielstein","year":"2001"},{"key":"10.1053\/ajkd.2002.32402_bib7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0272-6386(98)70087-3","article-title":"Genetic testing for renal diseases: Medical and ethical considerations","volume":"32","author":"Marsick","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.32402_bib8","year":"1996"},{"key":"10.1053\/ajkd.2002.32402_bib9","first-page":"277","article-title":"Ethical issues and cystic kidney","author":"Weil","year":"1990"},{"key":"10.1053\/ajkd.2002.32402_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1523-1755.1999.00552.x","article-title":"Phenotypic variability in PKD1: The family as a starting point","volume":"56","author":"Guay-Woodford","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.32402_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ndt\/14.3.631","article-title":"Long-term follow-up of a family with autosomal dominant polycystic kidney disease type 3","volume":"14","author":"de Almeida","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.32402_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.19-8-265","article-title":"Consultation with the specialist. Familial nephritis\/Alport syndrome","volume":"19","author":"Fouser","year":"1998","journal-title":"Pediatr Rev"},{"key":"10.1053\/ajkd.2002.32402_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/302106","article-title":"Determination of genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome","volume":"63","author":"Boye","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1053\/ajkd.2002.32402_bib14","first-page":"81","article-title":"Clinical and clinical-ethical aspects of genetic prediction: The case of hereditary kidney disorders","volume":"4","author":"Kielstein","year":"1996","journal-title":"Annu Rev Law Ethics"},{"key":"10.1053\/ajkd.2002.32402_bib15","first-page":"39","article-title":"Ethical issues and genetic counselling","volume":"vol 115","author":"Grantham","year":"1995"},{"key":"10.1053\/ajkd.2002.32402_bib16","series-title":"Genetic Testing and Privacy","author":"The Privacy Commissioner of Canada","year":"1992"},{"key":"10.1053\/ajkd.2002.32402_bib17","first-page":"65","article-title":"Case study on autosomal dominant polycystic kidney disease","author":"Gabow","year":"1993"},{"key":"10.1053\/ajkd.2002.32402_bib18","year":"1993"},{"key":"10.1053\/ajkd.2002.32402_bib19","first-page":"319","article-title":"Genetic testing for patients with renal disease: Procedures, pitfalls, and ethical considerations","volume":"19","author":"Korf","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1053\/ajkd.2002.32402_bib20","series-title":"Early Warning. Cases and Ethical Guidance for Pre-Symptomatic Testing in Genetic Diseases","author":"Smith","year":"1998"},{"key":"10.1053\/ajkd.2002.32402_bib21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/bmj.306.6889.1391","article-title":"Research samples from families with genetic diseases: A proposed code of conduct","volume":"306","author":"Harper","year":"1993","journal-title":"BMJ"},{"key":"10.1053\/ajkd.2002.32402_bib22","first-page":"469","article-title":"Ethical issues in genetic screening and testing, gene therapy, and scientific conduct. Handbook of Psychiatric Diseases","author":"Parker","year":"1997"},{"key":"10.1053\/ajkd.2002.32402_bib23","first-page":"451","article-title":"Genetic secrets","author":"Rothstein","year":"1997"},{"key":"10.1053\/ajkd.2002.32402_bib25","first-page":"9","article-title":"Proposed International Guidelines on Ethical Issues in Medical Genetics and Medical Services","author":"World Health Organization","year":"1998"},{"key":"10.1053\/ajkd.2002.32402_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1076\/jmep.23.3.288.2577","article-title":"Genotyping in clinical trials","volume":"23","author":"Sass","year":"1998","journal-title":"J Med Philos"},{"key":"10.1053\/ajkd.2002.32402_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ndt\/16.4.793","article-title":"Baseline blood pressure and other variables influencing survival on haemodialysis of patient without overt cardiovascular disease","volume":"16","author":"Galvao de Lima","year":"2001","journal-title":"Nephr Dial Transpl"},{"key":"10.1053\/ajkd.2002.32402_bib28","series-title":"Q&A on PKD","author":"Gabow","year":"1994"},{"key":"10.1053\/ajkd.2002.32402_bib29","series-title":"Your Child, Your Family, and Autosomal Recessive Polycystic Kidney Disease","author":"Guay-Woodford","year":"1996"},{"key":"10.1053\/ajkd.2002.32402_bib30","series-title":"The Family and ADPKD. A Guide for Children and Parents","author":"Chapman","year":"1997"},{"key":"10.1053\/ajkd.2002.32402_bib31","unstructured":"www.zystennieren.de"},{"key":"10.1053\/ajkd.2002.32402_bib32","unstructured":"www.pkdcure.org"},{"key":"10.1053\/ajkd.2002.32402_bib33","unstructured":"www.vhl.org"},{"key":"10.1053\/ajkd.2002.32402_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<299::AID-DVG13>3.0.CO;2-J","article-title":"Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney","volume":"24","author":"van Adelsberg","year":"1999","journal-title":"Dev Genet"},{"key":"10.1053\/ajkd.2002.32402_bib35","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1074\/jbc.273.11.6013","article-title":"The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1","volume":"273","author":"Arnould","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/ajkd.2002.32402_bib36","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0272-6386(96)90525-9","article-title":"Modification of disease progression in rats with inherited polycystic kidney disease","volume":"27","author":"Cowley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.32402_bib37","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ndt\/14.3.544","article-title":"Cyst formation in ADPKD: New insights from natural and targeted mutants","volume":"14","author":"Ong","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.32402_bib38","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ndt\/12.6.1132","article-title":"Von Hippel-Lindau disease: An important differential diagnosis of polycystic kidney disease","volume":"12","author":"Browne","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.32402_bib39","first-page":"1387","article-title":"Role of transforming growth factor-alpha in von Hippel-Lindau (VHL) (-\/-) clear cell renal carcinoma proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis","volume":"98","author":"de Paulsen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/ajkd.2002.32402_bib40","first-page":"125","volume":"1","year":"1996","journal-title":"Med Genetik"},{"key":"10.1053\/ajkd.2002.32402_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1009972728031","article-title":"Value neutrality in genetic counseling: An unattained ideal","volume":"4","author":"Rentmeester","year":"2001","journal-title":"Med Health Care Philos"},{"key":"10.1053\/ajkd.2002.32402_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2307\/3528534","article-title":"Making responsible decisions. An interpretive ethic for genetic decisionmaking","volume":"29","author":"White","year":"1999","journal-title":"Hastings Cent Rep"},{"key":"10.1053\/ajkd.2002.32402_bib43","first-page":"130","article-title":"\u201ccontract model\u201d for genetic research and health care for individuals and families","volume":"11","author":"Sass","year":"2001","journal-title":"Eubios J Asian Int Bioethics"},{"key":"10.1053\/ajkd.2002.32402_bib44","first-page":"81","article-title":"Genetic therapy, disability and enhancement","volume":"4","author":"Kamm","year":"1996","journal-title":"Annu Rev Law Ethics"},{"key":"10.1053\/ajkd.2002.32402_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1992.03480010067026","article-title":"How strictly do dialysis patients want their advance directives followed?","volume":"267","author":"Seghal","year":"1992","journal-title":"JAMA"},{"key":"10.1053\/ajkd.2002.32402_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1353\/ken.0.0247","article-title":"Using stories to assess values and establish medical directives","volume":"3","author":"Kielstein","year":"1993","journal-title":"Kennedy Inst Ethics J"},{"key":"10.1053\/ajkd.2002.32402_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/35074225","article-title":"Patientenverfuegung und Betreuungsvollmacht","author":"Sass","year":"2001","journal-title":"Munster-London, Lit"},{"key":"10.1053\/ajkd.2002.32402_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/gte.1998.2.37","article-title":"Developing genetic privacy legislation: The South Carolina experience","volume":"2","author":"Edwards","year":"1998","journal-title":"Genet Test"},{"key":"10.1053\/ajkd.2002.32402_bib49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/ajkd.2001.27855","article-title":"Discontinuing immunosuppression in a child with a renal transplant: Are there limits to withdrawing life support?","volume":"38","author":"Truog","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.32402_bib50","first-page":"867","article-title":"Leitlinien zur Gestaltung der Patiente-bzw Probandeninformation und der Einverstaendniserklaerung bei genetischen Studien (inkl. Pharmakogenetik)","volume":"113","author":"Mannhalter","year":"2001","journal-title":"Wiener Klin Wochenschr"},{"key":"10.1053\/ajkd.2002.32402_bib51","series-title":"Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis","author":"Renal Physicians Association and American Society of Nephrology","year":"2000"},{"key":"10.1053\/ajkd.2002.32402_NEWBIB1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jmp\/17.4.395","article-title":"Right not to know or duty to know? Prenatal screening for polycystic renal disease","volume":"17","author":"Kielstein","year":"1992","journal-title":"J Med Philos"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602028160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602028160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T17:22:59Z","timestamp":1546190579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602028160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0272638602028160"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2002.32402","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}